Application 210496

Type
NDA
Sponsor
ARRAY BIOPHARMA INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BRAFTOVIENCORAFENIBCAPSULE;ORAL50MGYesNo
002BRAFTOVIENCORAFENIBCAPSULE;ORAL75MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
70255-020BRAFTOVIEncorafenibArray BioPharma Inc.NDACurrent
70255-020BRAFTOVIEncorafenibArray BioPharma Inc.NDACurrent
70255-025BRAFTOVIEncorafenibArray BioPharma Inc.NDACurrent
70255-025BRAFTOVIEncorafenibArray BioPharma Inc.NDACurrent
70255-025BRAFTOVIEncorafenibArray BioPharma Inc.NDACurrent
70255-025BRAFTOVIEncorafenibArray BioPharma Inc.NDACurrent
70255-025BRAFTOVIEncorafenibArray BioPharma Inc.NDACurrent
70255-025BRAFTOVIEncorafenibArray BioPharma Inc.NDACurrent
70255-025BRAFTOVIEncorafenibArray BioPharma Inc.NDACurrent
70255-025BRAFTOVIEncorafenibArray BioPharma Inc.NDACurrent
70255-025BRAFTOVIEncorafenibArray BioPharma Inc.NDACurrent
70255-025BRAFTOVIEncorafenibArray BioPharma Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85264SUPPL 2026-03-04
85263SUPPL 2026-03-04
85165SUPPL 2026-02-25
85164SUPPL 2026-02-25
85161SUPPL 2026-02-25
83068SUPPL 2025-08-11
81580SUPPL 2025-03-17
81564SUPPL 2025-03-14
80709SUPPL 2024-12-26
80673SUPPL 2024-12-20
79615SUPPL 2024-09-16
79592SUPPL 2024-09-16
75793SUPPL 2023-10-17
75767SUPPL 2023-10-16
75721SUPPL 2023-10-13
75706SUPPL 2023-10-11
70167SUPPL2022-02-15
70160SUPPL2022-02-14
70159SUPPL2022-02-14
62522SUPPL2020-04-10
62509SUPPL2020-04-08
58935SUPPL2019-06-04
58869SUPPL2019-05-29
58868SUPPL2019-05-29
57547SUPPL2019-02-13
57340SUPPL2019-01-25
54909ORIG2018-07-18
54852ORIG2018-07-06
54695ORIG2018-06-27